KV1.3 THERAPEUTICS, INC.

Profile

Company Names

KV1.3 THERAPEUTICS, INC.

Addresses

219 TERRY AVE. N., SUITE 300, SEATTLE, WA 98109-5208

Phone Numbers

2063780400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

WASHINGTON

Total Amount Raised:

$184,182.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2018-01-05 
$168,182.00 
$5,000,000.00 
$4,831,818.00 
Debt 
1
2017-11-28 
$16,000.00 
$5,000,000.00 
$4,984,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LUCIEN 
 
FOUKE 
DIRECTOR
KV1.3 THERAPEUTICS, INC.
ROBERT 
 
HEDEQUIST 
DIRECTOR
KINETA, INC.   |  KINETA CHRONIC PAIN, LLC   |  KINETA IMMUNO-ONCOLOGY, LLC   |  KV1.3 THERAPEUTICS, INC.
SHAWN 
 
IADONATO 
DIRECTOR
KINETA, INC.   |  KINETA IO, LLC   |  KPI THERAPEUTICS, INC.   |  KINETA VIRAL HEMORRHAGIC FEVER, LLC   |  KINETA IMMUNO-ONCOLOGY, LLC   |  KINETA CHRONIC PAIN, LLC   |  KV1.3 THERAPEUTICS, INC.   |  KINETA, INC./DE
GAVIN 
 
JANCKE 
DIRECTOR
KV1.3 THERAPEUTICS, INC.
CRAIG 
 
PHILIPS 
EXECUTIVE OFFICER
KPI THERAPEUTICS, INC.   |  KV1.3 THERAPEUTICS, INC.   |  KINETA, INC.
DANIEL 
 
RAYMOND 
DIRECTOR
RVC 360, LLC   |  PLANTS OF RUSKIN GPS, LLC   |  KV1.3 THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-01-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-01-05 
2017-12-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#